Cardiovascular Diseases and Acute Heart Care

The Institutul De Boli Cardiovasculare Timisoara is conducting clinical research focused on cardiovascular diseases, with particular attention to urgent heart conditions such as STEMI, atherosclerotic cardiovascular disease, and heart failure. These studies are designed to test new treatments and improve outcomes for people at high risk of serious cardiac events.

  • Testing a new therapy for patients with an acute heart attack to improve early clinical outcomes
  • Evaluating treatment options for non-ischemic cardiomyopathy and advanced heart failure
  • Assessing approaches aimed at reducing major cardiovascular complications in high-risk patients

Research at this site also includes efforts to better understand the safety of new interventions, especially in time-sensitive cardiovascular emergencies.

Nutritional and Metabolic Diseases with Cardiovascular Risk

Another major focus at this cardiology site is the link between nutritional and metabolic diseases and long-term heart health. Trials are exploring conditions such as obesity, overweight, hypertension, and elevated lipoprotein(a), with the goal of lowering cardiovascular risk and preventing future complications.

  • Studying therapies for people with obesity and related heart and kidney risks
  • Investigating treatment strategies for hypertension that remains difficult to control
  • Evaluating new options for patients with elevated lipoprotein(a) and established cardiovascular disease

These studies aim to improve prevention, reduce major adverse cardiovascular events, and support better long-term management of metabolic risk factors.

Atherosclerotic Cardiovascular Disease and Prevention

Clinical trials at Institutul De Boli Cardiovasculare Timisoara are also centered on atherosclerotic cardiovascular disease, including patients with high cardiovascular risk, chronic kidney disease, and systemic inflammation. The research is focused on testing new therapies that may help prevent heart attacks, strokes, and other major events.

  • Assessing treatments intended to reduce the risk of major adverse cardiovascular events
  • Studying therapies for patients with ASCVD and chronic kidney disease
  • Exploring approaches to lower inflammation-related cardiovascular risk

This work supports a broader effort to improve prevention and long-term care for people living with advanced cardiovascular disease.